Ayurcann Holdings Balance Sheet Health

Financial Health criteria checks 3/6

Ayurcann Holdings has a total shareholder equity of CA$178.2K and total debt of CA$436.3K, which brings its debt-to-equity ratio to 244.9%. Its total assets and total liabilities are CA$16.7M and CA$16.5M respectively.

Key information

244.9%

Debt to equity ratio

CA$436.29k

Debt

Interest coverage ration/a
CashCA$891.78k
EquityCA$178.17k
Total liabilitiesCA$16.51m
Total assetsCA$16.68m

Recent financial health updates

No updates

Recent updates

Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Jun 28
Even With A 88% Surge, Cautious Investors Are Not Rewarding Ayurcann Holdings Corp.'s (CSE:AYUR) Performance Completely

Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

May 11
Not Many Are Piling Into Ayurcann Holdings Corp. (CSE:AYUR) Stock Yet As It Plummets 33%

Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Mar 22
Market Cool On Ayurcann Holdings Corp.'s (CSE:AYUR) Revenues Pushing Shares 29% Lower

Financial Position Analysis

Short Term Liabilities: AYUR's short term assets (CA$13.5M) do not cover its short term liabilities (CA$15.8M).

Long Term Liabilities: AYUR's short term assets (CA$13.5M) exceed its long term liabilities (CA$665.0K).


Debt to Equity History and Analysis

Debt Level: AYUR has more cash than its total debt.

Reducing Debt: AYUR's debt to equity ratio has increased from 20.7% to 244.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AYUR has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: AYUR has less than a year of cash runway if free cash flow continues to grow at historical rates of 34.8% each year.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 16:14
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ayurcann Holdings Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.